Novo Nordisk says Catalent buyout to close soon as regulatory conditions met
Novo Nordisk (NVO) announced Saturday that its pending acquisition of three Catalent (NYSE:CTLT) production sites is expected to close within days as its parent entity satisfied all regulatory conditions to buy the U.
Catalent And Novo Holdings Complete All Regulatory Closing Conditions For Merger
Catalent Inc. (CTLT) and Novo Holdings A/S announced that the companies have fulfilled all regulatory closing conditions for their
Regulatory conditions on Novo Holdings' $16.5 billion Catalent deal fulfilled, companies say
All regulatory closing conditions related to Novo Holdings' $16.5 billion acquisition of U.S. contract drug maker Catalent had been fulfilled, the companies said on Saturday, adding that the transaction is expected to be completed in the coming days.
Catalent gains after report sale to Novo Holdings could close soon
Catalent (CTLT) stock rises on reports of imminent $16.5 billion sale to Novo Holdings with FTC approval and EU Commission clearance.
Novo says Catalent deal regulatory closing conditions fulfilled
Novo Nordisk (NVO) announced that as of today, all regulatory closing conditions relating to the review of its pending acquisition of Catalent
Novo Nordisk Set to Close Catalent Deal Without FTC Challenge
Novo Nordisk A/S can advance with its acquisition of factories from contract development and manufacturing organization Catalent Inc. after the Federal Trade Commission declined to challenge the deal.
bovnews5d
CTLT’s Unexpected Surge: What’s Next?
Robert W. Baird has recently raised Catalent Inc (CTLT) stock to Outperform rating, as announced on November 16, 2023, according to Finviz. Earlier, on September 5, 2023, Argus had raised the stock ...
Yahoo Finance3d
Catalent, Inc. (CTLT)
As of 1:58:22 PM EST. Market Open. SOMERSET, N.J. & COPENHAGEN, Denmark, December 06, 2024--Catalent, Inc. ("Catalent," NYSE: CTLT), a leader in enabling the ...
Benzinga.com2d
Catalent (NYSE:CTLT) Stock Quotes, Forecast and News Summary
Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition Roche reported a 9% increase in third-quarter sales, driven by strong ...
bovnews3d
Analysts Predict a $53 Target for Catalent Inc (CTLT) Stock—What Could Drive It There?
Catalent Inc (CTLT) stock saw a modest uptick, ending the day at $63.24 which represents a slight increase of $1.00 or 1.61% from the prior close of $62.24. The stock opened at $62.5 and touched a low ...
Catalent, Inc. (NYSE:CTLT) Receives $63.40 Average Target Price from Brokerages
Catalent, Inc. (NYSE:CTLT – Get Free Report) has been assigned an average rating of “Hold” from the seven research firms that ...